Copyright
        ©2013 Baishideng Publishing Group Co.
    
    
        World J Cardiol. Apr 26, 2013; 5(4): 87-93
Published online Apr 26, 2013. doi: 10.4330/wjc.v5.i4.87
Published online Apr 26, 2013. doi: 10.4330/wjc.v5.i4.87
            Table 1 Drugs that prolong the QT interval and/or induce torsades de pointes
        
    | Drugs to be avoided in patients with c-long QT syndrome | |
| Class | Generic name | 
| Anesthetic | Sevoflurane | 
| Anti-anginal | Ranolazine, Bepridil | 
| Anti-arrhythmic | Sotalol, Quinidine, Amiodarone, Ibutilide, Disopyramide, Procainamide, Flecainide, Dofetilide, Dronedarone | 
| Antibiotic | Moxifloxacin, Clarithromycin, Ciprofloxacin, Gemifloxacin, Ofloxacin Telithromycin, Levofloxacin, Roxithromycin, Trimethoprim-Sulfa, Gatifloxacin, Sparfloxacin, Azithromycin Erythromycin | 
| Anti-cancer | Tamoxifen, Lapatinib, Nilotinib, Arsenic trioxide, Eribulin, Sunitinib | 
| Vandetanib | |
| Anti-convulsivant | Fosphenytoin, Felbamate | 
| Anti-depressant | Mirtazapine, Citalopram, Venlafaxine, Paroxetine, Fluoxetine, Sertraline, Trazodone, Escitalopram, Clomipramine, Amitriptyline, Imipramine, Nortriptyline, Desipramine, Doxepin, Trimipramine, Protriptyline | 
| Anti-fungal | Voriconazole, Fluconazole, Ketoconazole, Itraconazole | 
| Antihistamine | Astemizole, Terfenadine, Diphenhydramine, Diphenhydramine | 
| Anti-hypertensive | Nicardipine, Isradipine, Moexipril/HCTZ | 
| Anti-infective | Pentamidine | 
| Antilipemic | Probucol | 
| Anti-malarial | Artenimol + piperaquine, Chloroquine, Halofantrine | 
| Anti-mania | Lithium | 
| Anti-nausea/antiemetic | Granisetron, Dolasetron, Ondansetron | 
| Anti-psychotic | Clozapine, Ziprasidone, Thioridazine, Risperidone, Mesoridazine, Quetiapine, Haloperidol, Pimozide, Amisulpride, Sertindole, Sertindole, Iloperidone, Paliperidone, Chlorpromazine | 
| Anti-viral | Foscarnet, Ritonavir, Atazanavir | 
| Appetite suppressant | Phentermine, Fenfluramine, Sibutramine | 
| Bladder Antispasmodic | Tolterodine | 
| α1-blocker | Alfuzosin | 
| Bronchodilator/decongestant | Albuterol, Salmeterol, Metaproterenol, Terbutaline, Metaproterenol, Levalbuterol, Ephedrine, Phenylpropanolamine, Pseudoephedrine | 
| Cholinesterase inhibitor | Galantamine | 
| CNS stimulant | Amphetamine | 
| Methylphenidate | |
| Amphetamine | |
| Dexmethylphenidate | |
| Methylphenidate | |
| Lisdexamfetamine | |
| Diuretic | Indapamide | 
| Dopaminergic/anti-viral/anti-infective/ | Amantadine | 
| Endocrine | Ocreotide | 
| GI stimulant | Cisapride | 
| H2-receptor antagonist | Famotidine | 
| Imaging contrast agent | Perflutren lipid microspheres | 
| Immunosuppressant | Tacrolimus, Fingolimod | 
| Inotropic agent/vasconstrictor | Dopamine, Isoproterenol, Dobutamine, Epinephrine, Norepinephrine, Phenylephrine | 
| Local anesthetic | Cocaine | 
| Muscarinic receptor anatagonist | Solifenacin | 
| Muscle relaxant | Tizanidine | 
| norepinephrine reuptake inhibitor | Atomoxetine | 
| Opiate agonist | Methadone, Levomethadyl | 
| Oxytocic | Oxytocin | 
| phosphodiesterase inhibitor/vasodilator | Vardenafil | 
| Sedative | Chloral hydrate | 
| Sedative; Anti-nausea/anesthesia adjunct | Droperidol | 
| Uterine relaxant | Ritodrine | 
| Vasconstrictor | Midodrine | 
            Table 2 Normal QT corrected using the Bazzet’s formula duration by age and gender
        
    | QT corrected using the Bazzet’s formula | |||
| QTc value (s) | Children (1-15 yr) | Male ( > 15 yr) | Female ( > 15 yr) | 
| Normal | < 0.44 | < 0.43 | < 0.45 | 
| Borderline | 0.44-0.46 | 0.43-0.45 | 0.45-0.46 | 
| Prolonged | > 0.46 | > 0.45 | > 0.46 | 
            Table 3 Electrocardiograph pattern in long QT syndrome
        
    | ECG in LQTS | |
| LQT1 | Prolonged QT, T wave normal or with increased amplitude with a wide base | 
| LQT2 | Prolonged QT, T wave with low amplitude and often bifid | 
| LQT3 | Late onset of the T wave, prolonged isoelectric segment | 
- Citation: Fazio G, Vernuccio F, Grutta G, Re GL. Drugs to be avoided in patients with long QT syndrome: Focus on the anaesthesiological management. World J Cardiol 2013; 5(4): 87-93
 - URL: https://www.wjgnet.com/1949-8462/full/v5/i4/87.htm
 - DOI: https://dx.doi.org/10.4330/wjc.v5.i4.87
 
